Table 2: Frequency of MDSC subsets in the peripheral blood of healthy donors, chronic pancreatitis, and pancreatic cancer patients.

PCCPHDs value

Lin-HLA-DR-2.7 (0.7–17.5)*1.9 (1–90.7)*4.3 (1.0–14.6)*A = 0.14, B = 0.59, C = 0.79
Lin-HLA-DR-CD33+11b+8.1 (1.4–27.6)*11.8 (0.5–34.2)*8.7 (0–19.2)*A = 0.6, B = 0.85, C = 0.89
Lin-HLA-DR-CD33+11b+CD15+8.8 (0–91.3)*8.9 (0–33.7)*1.4 (0–14.5)*A  =  0.0003, B = 0.65, C = 0.13
Lin-HLA-DR-CD14+0.8 (0.2–6.6)*1.6 (0.4–6.3)*1.3 (0.16–3.5)*A = 0.47, B = 0.43, C = 0.63
HLA-DR-/lowCD14+0.9 (0.2–7.5)*2.2 (0.2–37.1)*1.8 (0.6–6.7)*A = 0.41, B = 0.83, C = 0.79
HLA-DR-/LowCD33+10.5 (1.9–31.2)*14.8 (0.4–93.1)*14.2 (1.4–23.9)*A = 0.69, B = 0.818, C = 0.89

PC: pancreatic cancer; CP: chronic pancreatitis; HDs: healthy donors. P value: A = (PC versus HDs); B = (PC versus CP); C = (CP versus HDs). Data shown represent median (range). The bold values refer to statistically significant values.